Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Amesite (AMST) Research & Development (2019 - 2025)

Amesite (AMST) has disclosed Research & Development for 7 consecutive years, with $164853.0 as the latest value for Q4 2025.

  • Quarterly Research & Development fell 22.19% to $164853.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $537979.0 through Dec 2025, down 18.19% year-over-year, with the annual reading at $691154.0 for FY2025, 35.67% down from the prior year.
  • Research & Development hit $164853.0 in Q4 2025 for Amesite, up from $33497.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $899951.0 in Q1 2022 to a low of $33497.0 in Q3 2025.
  • Historically, Research & Development has averaged $392742.7 across 5 years, with a median of $332274.0 in 2023.
  • Biggest five-year swings in Research & Development: soared 78.62% in 2021 and later tumbled 89.18% in 2024.
  • Year by year, Research & Development stood at $681018.0 in 2021, then tumbled by 36.7% to $431087.0 in 2022, then dropped by 23.17% to $331224.0 in 2023, then tumbled by 36.04% to $211867.0 in 2024, then fell by 22.19% to $164853.0 in 2025.
  • Business Quant data shows Research & Development for AMST at $164853.0 in Q4 2025, $33497.0 in Q3 2025, and $167531.0 in Q2 2025.